Andrew W. Michell

Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis

Sarosh R. Irani, Andrew W. Michell, Bethan Lang et al. · Annals of Neurology · 2010 · 885 citations

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

Peter Connick, Madhan Kolappan, Charles Crawley et al. · The Lancet Neurology · 2012 · 602 citations · Full text

Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles

Benjamin R. Underwood, David Broadhurst, Warwick B. Dunn et al. · Brain · 2006 · 186 citations · Full text

Genetics, Genetic Epidemiology, Metabolomic Profiling +18

The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments

Peter Connick, Madhan Kolappan, Rickie Patani et al. · Trials · 2011 · 118 citations · Full text

Metabolomic analysis of urine and serum in Parkinson’s disease

Andrew W. Michell, David E. Mosedale, David J. Grainger et al. · Metabolomics · 2008 · 94 citations

Biochemistry, Metabolomic Analysis, Metabolomic Profiling +5